Literature DB >> 23566496

RETRACTED: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients.

Jagadeesh Sridhara Rao1, Hyung-Wook Kim2, Gaylia Jean Harry3, Stanley Isaac Rapoport2, Edmund Arthur Reese2.   

Abstract

This article has been retracted: please see Elsevier Policy on Article Withdrawal (https://www.elsevier.com/about/our-business/policies/article-withdrawal). This article has been retracted at the request of the Editors. The National Institutes of Health has found that Dr. Jagadeesh S. Rao engaged in research misconduct by falsifying data. Data in Figures 1A, 1E, 3E and 3F were falsified. Dr. Rao was solely responsible for the falsification. None of the other authors are implicated in any way. Published by Elsevier B.V.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23566496      PMCID： PMC3812915          DOI： 10.1016/j.schres.2013.02.017

Source DB:  PubMed          Journal:  Schizophr Res        ISSN： 0920-9964            Impact factor:   4.939


  70 in total

1.  An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia.

Authors:  N Laflamme; S Lacroix; S Rivest
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients.

Authors:  J K Yao; S Leonard; R D Reddy
Journal:  Schizophr Res       Date:  2000-03-16       Impact factor: 4.939

Review 3.  Neurochemical consequences of kainate-induced toxicity in brain: involvement of arachidonic acid release and prevention of toxicity by phospholipase A(2) inhibitors.

Authors:  A A Farooqui; W Yi Ong; X R Lu; B Halliwell; L A Horrocks
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  I P Everall; R K Heaton; T D Marcotte; R J Ellis; J A McCutchan; J H Atkinson; I Grant; M Mallory; E Masliah
Journal:  Brain Pathol       Date:  1999-04       Impact factor: 6.508

5.  RETRACTED: Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients.

Authors:  Jagadeesh Sridhara Rao; Matthew Kellom; Edmund Arthur Reese; Stanley Isaac Rapoport; Hyung-Wook Kim
Journal:  J Affect Disord       Date:  2011-09-16       Impact factor: 4.839

6.  Memory functions in geriatric chronic schizophrenic patients: a neuropsychological study.

Authors:  P D Harvey; P Powchik; R C Mohs; M Davidson
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1995       Impact factor: 2.198

7.  Plasma prostaglandin E2 metabolite--measured as 11-deoxy-15-keto-13,14-dihydro-11 beta,16 xi-cyclo-PGE2--in twins with schizophrenic disorder.

Authors:  A A Mathé; G Eberhard; J Sääf; L Wetterberg
Journal:  Biol Psychiatry       Date:  1986-09       Impact factor: 13.382

8.  Patients with schizophrenia show raised serum levels of the pro-inflammatory chemokine CCL2: association with the metabolic syndrome in patients?

Authors:  Roosmarijn C Drexhage; Roos C Padmos; Harm de Wit; Marjan A Versnel; Herbert Hooijkaas; Aart-Jan van der Lely; Nico van Beveren; Roel H deRijk; Dan Cohen
Journal:  Schizophr Res       Date:  2008-05-16       Impact factor: 4.939

9.  Association between BanI genotype and increased phospholipase A2 activity in schizophrenia.

Authors:  Nadia R Barbosa; Ricardo M Junqueira; Homero P Vallada; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-07-14       Impact factor: 5.270

10.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence for a monoaminergic mechanism.

Authors:  D R Weinberger; K F Berman; B P Illowsky
Journal:  Arch Gen Psychiatry       Date:  1988-07
View more
  47 in total

Review 1.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

Review 2.  Brain imaging during the transition from psychosis prodrome to schizophrenia.

Authors:  Yoonho Chung; Tyrone D Cannon
Journal:  J Nerv Ment Dis       Date:  2015-05       Impact factor: 2.254

3.  Kynurenine is correlated with IL-1β in plasma of schizophrenia patients.

Authors:  Helena P G Joaquim; Alana C Costa; Wagner F Gattaz; Leda Leme Talib
Journal:  J Neural Transm (Vienna)       Date:  2018-01-06       Impact factor: 3.575

4.  Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.

Authors:  B S Fernandes; J Steiner; M Berk; M L Molendijk; A Gonzalez-Pinto; C W Turck; P Nardin; C-A Gonçalves
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

5.  In utero exposure to fine particulate matter results in an altered neuroimmune phenotype in adult mice.

Authors:  Joshua A Kulas; Jordan V Hettwer; Mona Sohrabi; Justine E Melvin; Gunjan D Manocha; Kendra L Puig; Matthew W Gorr; Vineeta Tanwar; Michael P McDonald; Loren E Wold; Colin K Combs
Journal:  Environ Pollut       Date:  2018-05-22       Impact factor: 8.071

6.  Levels of Red Blood Cell Fatty Acids in Patients With Psychosis, Their Unaffected Siblings, and Healthy Controls.

Authors:  Suzanne Medema; Roel J T Mocking; Maarten W J Koeter; Frédéric M Vaz; Carin Meijer; Lieuwe de Haan; Nico J M van Beveren; René Kahn; Lieuwe de Haan; Jim van Os; Durk Wiersma; Richard Bruggeman; Wiepke Cahn; Carin Meijer; Inez Myin-Germeys
Journal:  Schizophr Bull       Date:  2015-09-18       Impact factor: 9.306

7.  Sex difference in the association of body mass index and BDNF levels in Chinese patients with chronic schizophrenia.

Authors:  Fang Yang; Keming Wang; Xiangdong Du; Huiqiong Deng; Hanjing Emily Wu; Guangzhong Yin; Yuping Ning; Xingbing Huang; Antonio L Teixeira; João de Quevedo; Jair C Soares; Xiaosi Li; XiaoE Lang; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2018-11-19       Impact factor: 4.530

8.  Lipidomics profile of a NAPE-PLD KO mouse provides evidence of a broader role of this enzyme in lipid metabolism in the brain.

Authors:  Emma Leishman; Ken Mackie; Serge Luquet; Heather B Bradshaw
Journal:  Biochim Biophys Acta       Date:  2016-03-05

Review 9.  Brain Biomarkers of Vulnerability and Progression to Psychosis.

Authors:  Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2015-12-09       Impact factor: 9.306

10.  Transcriptome-wide mega-analyses reveal joint dysregulation of immunologic genes and transcription regulators in brain and blood in schizophrenia.

Authors:  Jonathan L Hess; Daniel S Tylee; Rahul Barve; Simone de Jong; Roel A Ophoff; Nishantha Kumarasinghe; Paul Tooney; Ulrich Schall; Erin Gardiner; Natalie Jane Beveridge; Rodney J Scott; Surangi Yasawardene; Antionette Perera; Jayan Mendis; Vaughan Carr; Brian Kelly; Murray Cairns; Ming T Tsuang; Stephen J Glatt
Journal:  Schizophr Res       Date:  2016-07-20       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.